Literature DB >> 12196055

Nephrotoxicity and purpura associated with levofloxacin.

Giuseppe Famularo1, Claudio De Simone.   

Abstract

OBJECTIVE: To report a patient with lung cancer and idiopathic myelofibrosis with myeloid metaplasia who developed purpura and acute renal failure while receiving levofloxacin, and review the existing literature on quinolone nephrotoxicity. CASE
SUMMARY: A 73-year-old white man, with a medical history of non-small-cell lung cancer and idiopathic myelofibrosis with myeloid metaplasia, was prescribed levofloxacin because of a lower urinary tract infection. Three days later, he presented with palpable purpura and erythematous skin lesions over the lower limbs and trunk, with a markedly reduced urinary output. Serum creatinine and urea nitrogen were 6.4 and 190 mg/dL, respectively. Levofloxacin was discontinued, and prednisone, furosemide, and intravenous fluids were given. The patient fully recovered over the ensuing 4 weeks.
CONCLUSIONS: Nephrotoxicity associated with levofloxacin is uncommon. Allergic interstitial nephritis or vasculitis is believed to be the underlying pathologic process. Definitive diagnosis requires performance of renal biopsy, although this is not always feasible. In this case, a return of renal function to normal, with the disappearance of purpura following the discontinuation of levofloxacin and corticosteroid treatment, supports the presumptive diagnosis of a hypersensitivity reaction to levofloxacin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196055     DOI: 10.1345/aph.1A474

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  7 in total

1.  Acute hepatitis associated with levofloxacin in a patient with renal insufficiency.

Authors:  Kelly Airey; Elizabeth Koller
Journal:  CMAJ       Date:  2003-10-14       Impact factor: 8.262

2.  Fluoroquinolone-induced serious, persistent, multisymptom adverse effects.

Authors:  Beatrice Alexandra Golomb; Hayley Jean Koslik; Alan J Redd
Journal:  BMJ Case Rep       Date:  2015-10-05

Review 3.  Safety considerations of fluoroquinolones in the elderly: an update.

Authors:  Ralf Stahlmann; Hartmut Lode
Journal:  Drugs Aging       Date:  2010-03-01       Impact factor: 3.923

4.  Cutaneous vasculitis associated with fluoroquinolones.

Authors:  G Maunz; T Conzett; W Zimmerli
Journal:  Infection       Date:  2009-08-07       Impact factor: 3.553

Review 5.  Ceftriaxone-induced leukocytoclastic vasculitis: a case report and literature review of antibiotic-induced leukocytoclastic vasculitis.

Authors:  Aseel A Almasoudi; Eman S Bablghaith; Samaher I Alaauldeen; Ayman M Falemban; Ahlam A Sherbeeni; Adeeb A Bulkhi
Journal:  J Int Med Res       Date:  2022-05       Impact factor: 1.573

6.  Nephrotoxicity of Ciprofloxacin: Five Cases and a Review of the Literature.

Authors:  Meriam Hajji; Hela Jebali; Aymen Mrad; Yassine Blel; Nozha Brahmi; Rania Kheder; Soumaya Beji; Lilia Ben Fatma; Wided Smaoui; Madiha Krid; Fethi Ben Hmida; Lamia Rais; Mohammed Karim Zouaghi
Journal:  Drug Saf Case Rep       Date:  2018-04-18

7.  Cutaneous leukocytoclastic vasculitis associated with levofloxacin therapy.

Authors:  Dana M Blyth; Elizabeth Markelz; Jason F Okulicz
Journal:  Infect Dis Rep       Date:  2012-01-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.